血清神经元特异性烯醇化酶水平在非霍奇金淋巴瘤中的临床意义

【参考文献】
  [1]Viallard JL,Tiget F,Hartmann O, et al. Serum neuronspecific / nonneuronal enolase ratio in the diagnosis of neuroblastomas[J]. Cancer, 1988, 62(12): 2546-2553.

[2] Riley RD, Heney D, Jones DR, et al. A systematic review of molecular and biological tumor markers in neuroblastoma [J]. Clin Cancer Res, 2004, 10: 4-12.

[3]James AB, Jeff AS, Kendrith MR, et al. Significance of neuronspecific enolase levels before and during therapy for small cell lung cancer [J]. Clin Cancer Res, 2000, 6 (2): 597-601.

[4]Nemeth J, Galian A, Miko J, et al. Neuronspecific enolase and malignant lymphomas [J]. Virchows Arch, 1987, 412: 89-93.

[5]Massarelli G，Onida GA, Piras MA, et al. Neuronspecific enolase (γ enolase, γγ dimer) expression in Hodgkin’s disease and large cell lymphomas [J]. Anticancer Res,1999, 19: 3933-3938.

[6]Fujiwara H, Arima N, Ohtsubo H, et al. Clinical significance of serum neuronspecific enolase in patients with adult Tcell lymphoma [J]. Am J Hematology, 2002, 71: 80-84.